ArticleCancer research communications2025

Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer Study.

Samantha I Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.